About Trivascular
Trivascular is a company based in Santa Rosa (United States) founded in 1998 by Joseph Humphrey. Trivascular has raised $260.95 million across 8 funding rounds from investors including Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group. The company has 307 employees. Trivascular operates in a competitive market with competitors including Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others.
- Headquarter Santa Rosa, United States
- Employees 307
- Founders Joseph Humphrey
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website trivascular.com
- Social LinkedIn X Facebook
- Total Equity Funding$260.95M (USD)
in 8 rounds
- Latest Funding Round$10M (USD), Post-IPO
Aug 2015
- InvestorsPinnacle Ventures
& 7 more
- Employee Count307
Funding Insights of Trivascular
Trivascular has successfully raised a total of $260.95M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $260.95M
- Total Rounds 8
- Last Round Post-IPO — $10M
- First Round $65M
(Mar 2008)
- Investors Count 8
All 8 funding rounds of Trivascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $10M | Post-IPO | – | – | – |
| Dec 2013 | $1.95M | Series D | – | – | – |
| Nov 2013 | $40M | Series E | – | – | |
| Jun 2012 | $60M | Series D | – | Kaiser Permanente Ventures | |
| Apr 2012 | $4M | Series A | – | – | – |
| Aug 2010 | $60M | Series C | – | – | |
| Nov 2009 | $30M | Series B | – | – | |
| Mar 2008 | $65M | Series A | – | – | – |
8 investors in total: 7 institutional and 1 angel.
Investors in Trivascular
Trivascular has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech and Life Sciences focused corporate VC firm investing in the US | – | kpventures.com | Oakland, United States | |
Venture capital investments are offered to startups by NEA. | – | nea.com | Menlo Park, United States | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
Venture debt and equity financing are provided across US sectors. | 2002 | pinnacleventures.com | Palo Alto, United States | |
Venture capital is invested in US life sciences companies. | – | kearnyvp.com | San Francisco, United States | |
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
Invests in biotech firms developing life-saving drugs and technologies. | – | mpmcapital.com | - | |
SB Sam Brasch | Angel investor and Senior Managing Director at Accel, focusing on tech startups | – | unknown_acf858019cf34835a | - |
Investor details for Trivascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Trivascular
1 people are tracked at Trivascular (1 in leadership); the tracked headcount is 307.
| Name | Role | Group |
|---|---|---|
Joseph Humphrey | Co-Founder | Leadership |
Complete people profiles for Trivascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Trivascular
4 dated milestones of Trivascular across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Trivascular is founded.
- Funding First funding round of $65.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $10.0M.
Competitors of Trivascular
Trivascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | – | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | |
| endoronmedical.com | 2019 | Kfar Saba, Israel | $15M | – | Endovascular fixation devices for cardiovascular stent grafts are manufactured. | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | – | Endovascular devices for aortic aneurysms are developed. | |
| aptusendo.com | 2002 | Sunnyvale, United States | $70M | 63 | Endograft anchoring systems for aortic aneurysms are developed. | |
| remonmedical.com | 1997 | Caesarea, Israel | $26M | – | Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics. | |
| endovastec.com | 2012 | Shanghai, China | – | – | Medical devices for treating aortic diseases are developed. | |
| nellix.com | 1994 | Palo Alto, United States | $18.2M | – | Medical device catering less invasive treatment of Abdominal Aortic Aneurysms | |
| emblok.com | 2013 | Kalamazoo, United States | $19.75M | – | Embolic protection devices are developed for TAVR procedures. | |
| jotec.com | 2000 | Hechingen, Germany | – | 451 | Stents and Grafts for Aortic and Peripheral arterial disease |
Detailed competitors of Trivascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Trivascular
Websites that share an audience with Trivascular (trivascular.com).
Websites whose visitors overlap most with Trivascular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| endologix.com | 100% | 5.4K | #2,329,965 | View details | |
| boltonmedical.com | 96% | – | – | View details | |
jevt.org | jevt.org | 69% | – | – | – |
Similar companies to Trivascular
10 companies that operate in the same segment as Trivascular (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trivascular
Trivascular was founded in 1998 and raised its 1st funding round 10 years after it was founded.
Trivascular is headquartered in Santa Rosa, United States.
Trivascular is a funded company, having raised a total of $260.95M across 8 funding rounds to date. The company's 1st funding round was a Series A of $65M, raised on Mar 2008.
Trivascular has 307 employees.
TriVascular was established in 1998 and is based in Santa Rosa, United States. Focus is placed on the medical device sector, where endovascular aortic repair solutions are developed and produced. The Ovation Abdominal Stent Graft System is provided to support treatments for abdominal aortic aneurysms, with FDA approval obtained for its use in clinical procedures. Operations center on innovation in graft profiling technology.
Trivascular's top competitors include Endologix, Shanghai MicroPort Endovascular MedTech and Jotec.
Trivascular has 8 investors. Key investors include Pinnacle Ventures, Kaiser Permanente Ventures, Redmile Group, NEA, and Delphi Ventures.